Study in End-stage Renal Disease Patients Awaiting Kidney Transplant to Investigate the Potential Effect of IVIG Treatment on the Pharmacokinetics and Pharmacodynamics of LFG316
Clinical trial NCT02878616 · COMPLETED
Trial details
- NCT number
- NCT02878616
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-26
- Primary completion
- 2017-07-19
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.